YIH
MYOV

Y-Intercept (HK)’s Myovant Sciences Ltd. MYOV Stock Holding History

Y-Intercept (HK)’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,198
Closed -$139K – 1366
2022
Q2 		$139K Buy
+11,198
New +$124K 0.02% 706

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Y-Intercept (HK)'s MYOV Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 11,198 shares — an estimated $139K sold.

Y-Intercept (HK) first reported a position in MYOV in Q2 2022 and held it in 1 quarter. The position peaked at $139K in Q2 2022. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Y-Intercept (HK) reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 11,198 Myovant Sciences Ltd. shares in Q3 2022, an estimated $139K.
  • Y-Intercept (HK) first reported a position in Myovant Sciences Ltd. in Q2 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s Myovant Sciences Ltd. position peaked at $139K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.